Your best protection from getting sick is a strong immune system
Over time, this can lead to noticeable improvements in waist circumference, metabolic health, and overall energy levels
As oral GLP-1 drugs could hit the market next year, brands across wellness and beauty are expected to rev up items to offset the effects, she said

For patients interested in participating in research , the following resources may be helpful: NIHR Be Part of Research (bepartofresearch.nihr.ac.uk) search for Parkinson's and GLP-1 trials Parkinson's UK (www.parkinsons.org.uk) information on current research and trial opportunities When to contact your GP or specialist : If you have Parkinson's disease and diabetes, and wish to discuss whether a GLP-1 receptor agonist is appropriate for your diabetes management If you experience new or worsening symptoms whilst taking any medication If you are interested in clinical trial participationyour neurologist can advise on suitable studies Seek urgent medical attention if you experience: Severe, persistent abdominal pain (possible pancreatitis) Persistent vomiting or inability to keep fluids down (risk of dehydration) Signs of dehydration (extreme thirst, dark urine, dizziness) Allergic reaction (rash, swelling, difficulty breathing) Patients should never start, stop, or modify medications without medical supervision

When two compounds share a final therapeutic outcome (tissue repair) but achieve it through different receptors and cellular intermediaries, their combination can produce effects that exceed what either compound delivers alone without requiring dose escalation of either component